scispace - formally typeset
B

Baba Coulibaly

Researcher at Pasteur Institute

Publications -  10
Citations -  55

Baba Coulibaly is an academic researcher from Pasteur Institute. The author has contributed to research in topics: Malaria & Population. The author has an hindex of 4, co-authored 7 publications receiving 40 citations.

Papers
More filters
Journal ArticleDOI

Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation.

TL;DR: This study found relative low coverage of IPTp in the study areas which supported findings that high ANC attendance does not guarantee high IPTP coverage and urgent efforts are required to improve service delivery of this important intervention.
Journal ArticleDOI

Cross sectional study on prevalence of sickle cell alleles S and C among patients with mild malaria in Ivory Coast.

TL;DR: A high proportion of patients with mild malaria carried genetic hemoglobin disorder, and this population of high risk must be better investigated to control treatment efficacy and to manage complications.
Journal ArticleDOI

Malaria parasite clearance from patients following artemisinin-based combination therapy in Côte d'Ivoire.

TL;DR: Investigating parasite clearance in patients treated with artesunate + amodiaquine (AS + AQ) and artemether + lumefantrine (AL): the two artemisinin-based combination therapies recommended in the first-line treatment of uncomplicated malaria in Côte d’Ivoire found ACTs are still efficacious, but continued efficacy monitoring of ACTs is needed.
Journal ArticleDOI

Comparative efficacy of uncontrolled and controlled intermittent preventive treatment during pregnancy (IPTp) with combined use of LLTNs in high resistance area to sulfadoxine-pyrimethamine in Côte d'Ivoire.

TL;DR: The study showed that the two IPTp-SP approaches were equivalent, suggesting that unsupervised IPTP-SP free of charge should be used in areas where implementation of the directly observed treatment scheme suffers from many constraints.